On a volunteer basis, more than 50 riders of the Tour de France have been tests for cortisol by MPCC, this Saturday, July 19.Â No medical contraindication has been made.More information
After having raised the issue of the credibility of a performance medicine a few weeks ago, MPCC now raise the issue of the sponsor's role in the policy to be set up in the fight against doping within a cycling team. Several speakers participated in the debate: AG2R La Mondiale's manager Vincent Lavenu, Cofidis' manager Yvon Sanquer, MPCC's chairman Roger Legeay and Marc Frederix, marketing director of Lotto.Â
The French Secretariat of State for Sport met the President and the doctor of MPCC following the requests by the movement earlier this year. Mister Thierry Braillard is committed to start thinking about adapting the rules of occupational medicine, particularly about corticosteroids.Â
The debate raised by the TUE granted to Chris Froome in the Tour of Romandie has been the center of discussions for several days.When questioned by Cyclingnews concerning the topic, the Giant-Shimano teamâ€™s doctor Anko Boelens took the opportunity to highlight the requirements of the MPCC regulation on the use of corticosteroids.
Contrary to popular belief, cycling is not the most affected sport by doping. MPCC fights to improve the credibility of the sport and this requires an awareness of the real trends. From now, every month, we will unveil the figures identifying the cases revealed in 2014, to better situate cycling compared to other disciplines.
11 MPCC's members on 18 teams
(5 on 19 in 2013)
16 MPCC's members on 17 teams
(5 on 20 in 2013)
31 MPCC's members on 181 teams
(0 on 158 in 2013)
8 MPCC's members on 32 teams
(0 on 35 in 2013)
We are convinced of the need for all the teams to agree on a new ethic code applicable for all teams and all the riders.
For the direction of our cycling team, it's imperative that all professional cycling teams take the necessary steps to show their commitment to fight together against the scourge of doping.